Role of osteopontin in cancer: From pathogenesis to therapeutics (Review)
Oncology Reports · 07.08.2025 · 54 (5) · 1-13
DOI: 10.3892/or.2025.8969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 07.08.2025. Verfasst von Wenli Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China. Hauptthemen laut MEDLINE: Osteopontin, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China.
- School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China.
- Department of Neurosurgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi 030…
Zitieren
APA
Xu, W., Bi, Z., Lu, L., Feng, F., Chen, L., & Zhang, C. (2025). Role of osteopontin in cancer: From pathogenesis to therapeutics (Review). Oncology Reports, 54(5), 1-13. https://doi.org/10.3892/or.2025.8969
Vancouver
Xu W, Bi Z, Lu L, Feng F, Chen L, Zhang C. Role of osteopontin in cancer: From pathogenesis to therapeutics (Review). Oncology Reports. 2025;54(5):1-13. doi:10.3892/or.2025.8969
BibTeX
@article{Xu2025,
author = {Xu, Wenli and Bi, Zhifei and Lu, Li and Feng, Fuqiang and Chen, Laizhao and Zhang, Chengwu},
title = {Role of osteopontin in cancer: From pathogenesis to therapeutics (Review)},
journal = {Oncology Reports},
year = {2025},
volume = {54},
number = {5},
pages = {1--13},
doi = {10.3892/or.2025.8969}
}
EUVIMED